"I’ve been using Affimer technology in my research for the past year and the data generated has been remarkable. My interest lies in understanding the mechanisms for blood clot formation and breakdown with the long-term aim of reducing heart attacks and strokes in high risk patients. A number of Affimer candidates have shown significant effects on the clotting process, which will help to develop novel therapeutic targets aiming to reduce thrombosis risk."
Dr Ramzi Ajjan
Associate Professor / Consultant, Diabetes and Endocrinology, University of Leeds and Leeds NHS Trust